Close Menu

Ohio State

Building on studies examining the roles of microRNAs in cancer cell-derived circulating microvesicles, a team of researcher from Ohio State University this month reported on the discovery that two such miRNAs trigger a pro-metastatic inflammatory response by binding to toll-like

Gen-Probe has been awarded US Patent No. 8,192,992, "System and method for incubating the contents of a reaction receptacle."
Kelly Ammann, Robert Schneider, and Robert Smith are named as inventors on the patent.

OSU's new P4 Scholars program educates medical students in predictive, preventive, personalized, and participatory medicine.

A study published earlier this spring by OSU researchers identified a set of miRNA signatures in blood that could yield a new test for lung cancer development and prognosis.

Researchers at OSU used the 75-teraflop supercomputer to perform sequence alignments and statistical analysis as well as to generate phylogenetic trees to shed light on the evolutionary history of the PARP protein family.

The aim of the effort is to assess the utility of incorporating genomic testing data in patients' electronic medical records.

The collaborators will study the use of genomic medicine, genetic counseling, and electronic medical records for heart disease and hypertension.


Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.